BLUELINX HOLDINGS INC (BXC)

US09624H2085 - Common Stock

108.54  -1.15 (-1.05%)

After market: 108.54 0 (0%)

Fundamental Rating

5

BXC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 51 industry peers in the Trading Companies & Distributors industry. While BXC has a great health rating, its profitability is only average at the moment. BXC has a valuation in line with the averages, but on the other hand it scores bad on growth.



4

1. Profitability

1.1 Basic Checks

In the past year BXC was profitable.
In the past year BXC had a positive cash flow from operations.
BXC had positive earnings in 4 of the past 5 years.
BXC had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of 3.16%, BXC is not doing good in the industry: 62.75% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of 7.66%, BXC is doing worse than 66.67% of the companies in the same industry.
With a Return On Invested Capital value of 7.05%, BXC perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for BXC is significantly above the industry average of 11.65%.
The 3 year average ROIC (18.99%) for BXC is well above the current ROIC(7.05%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.16%
ROE 7.66%
ROIC 7.05%
ROA(3y)15.17%
ROA(5y)10.28%
ROE(3y)46.46%
ROE(5y)N/A
ROIC(3y)18.99%
ROIC(5y)13.92%

1.3 Margins

BXC has a Profit Margin of 1.55%. This is in the lower half of the industry: BXC underperforms 74.51% of its industry peers.
In the last couple of years the Profit Margin of BXC has declined.
BXC has a Operating Margin of 4.42%. This is in the lower half of the industry: BXC underperforms 72.55% of its industry peers.
BXC's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 16.80%, BXC is not doing good in the industry: 86.27% of the companies in the same industry are doing better.
BXC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.42%
PM (TTM) 1.55%
GM 16.8%
OM growth 3Y1.26%
OM growth 5Y59.87%
PM growth 3Y-16.01%
PM growth 5YN/A
GM growth 3Y2.9%
GM growth 5Y7.71%

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BXC is creating value.
Compared to 1 year ago, BXC has less shares outstanding
Compared to 5 years ago, BXC has less shares outstanding
BXC has a better debt/assets ratio than last year.

2.2 Solvency

BXC has an Altman-Z score of 4.10. This indicates that BXC is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BXC (4.10) is better than 74.51% of its industry peers.
BXC has a debt to FCF ratio of 2.08. This is a good value and a sign of high solvency as BXC would need 2.08 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.08, BXC is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
BXC has a Debt/Equity ratio of 0.90. This is a neutral value indicating BXC is somewhat dependend on debt financing.
BXC has a Debt to Equity ratio (0.90) which is in line with its industry peers.
Although BXC does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 2.08
Altman-Z 4.1
ROIC/WACC0.81
WACC8.75%

2.3 Liquidity

BXC has a Current Ratio of 5.13. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.13, BXC belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 3.55 indicates that BXC has no problem at all paying its short term obligations.
BXC has a better Quick ratio (3.55) than 96.08% of its industry peers.
Industry RankSector Rank
Current Ratio 5.13
Quick Ratio 3.55

2

3. Growth

3.1 Past

The earnings per share for BXC have decreased strongly by -62.82% in the last year.
The Earnings Per Share has been growing by 10.63% on average over the past years. This is quite good.
Looking at the last year, BXC shows a very negative growth in Revenue. The Revenue has decreased by -29.52% in the last year.
Measured over the past years, BXC shows a small growth in Revenue. The Revenue has been growing by 1.84% on average per year.
EPS 1Y (TTM)-62.82%
EPS 3Y10.63%
EPS 5YN/A
EPS growth Q2Q-16%
Revenue 1Y (TTM)-29.52%
Revenue growth 3Y0.42%
Revenue growth 5Y1.84%
Revenue growth Q2Q-15.96%

3.2 Future

Based on estimates for the next years, BXC will show a decrease in Earnings Per Share. The EPS will decrease by -0.95% on average per year.
The Revenue is expected to grow by 1.11% on average over the next years.
EPS Next Y-24.69%
EPS Next 2Y-0.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.45%
Revenue Next 2Y1.11%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.55 indicates a reasonable valuation of BXC.
88.24% of the companies in the same industry are more expensive than BXC, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 24.76. BXC is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 12.69, the valuation of BXC can be described as correct.
Based on the Price/Forward Earnings ratio, BXC is valued a bit cheaper than 74.51% of the companies in the same industry.
BXC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.26.
Industry RankSector Rank
PE 9.55
Fwd PE 12.69

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BXC is valued cheaply inside the industry as 80.39% of the companies are valued more expensively.
96.08% of the companies in the same industry are more expensive than BXC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.37
EV/EBITDA 5.9

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.95%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BXC!.
Industry RankSector Rank
Dividend Yield N/A

BLUELINX HOLDINGS INC

NYSE:BXC (4/19/2024, 7:04:01 PM)

After market: 108.54 0 (0%)

108.54

-1.15 (-1.05%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap938.87M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 9.55
Fwd PE 12.69
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.16%
ROE 7.66%
ROCE
ROIC
ROICexc
ROICexgc
OM 4.42%
PM (TTM) 1.55%
GM 16.8%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.04
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 5.13
Quick Ratio 3.55
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-62.82%
EPS 3Y10.63%
EPS 5Y
EPS growth Q2Q
EPS Next Y-24.69%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-29.52%
Revenue growth 3Y0.42%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y